Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab and Dexamethasone in Relapsed Indolent Lymphoma
NCT00003663Phase 2Withdrawn
- Sponsor
- Hoag Memorial Hospital Presbyterian
- Start
- Jun 1998
- Primary completion
- Jan 2000
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of rituximab in Indolent Non-Hodgkin Lymphoma (INHL), sponsored by Hoag Memorial Hospital Presbyterian. Planned start Jun 1998; status: withdrawn.
02
Drugs
rituximab
03
Conditions
Indolent Non-Hodgkin Lymphoma (INHL)
Beyond the preview
Go deeper on NCT00003663.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003663.